Prof. Dr. med. Markus Gerhard
Prof. Dr. med. Markus Gerhard obtained his Ph.D. (summa cum laude) from the University of Hamburg and his medical board license in 1996.
From 1997 to 2010 he worked at the Second Medical Department at the “Klinikum rechts der Isar”, the medical clinic affiliated with the Technische Universität München (TUM). He was appointed Professor at the Institute for Medical Microbiology and Immunology at the TUM in January 2011. His scientific work focuses on diseases caused by pathogens causing chronic infections, immune evasion mechanisms of pathogens and inflammation-associated carcinogenesis, particularly Helicobacter pylori. Prof. Markus Gerhard has published numerous papers in renowned international journals and received several awards.
In 2003, the Bavarian government awarded Prof. Markus Gerhard with the “Habilitationsförderpreis”, a grant awarded to the most talented junior researchers for work qualifying them as professors. In 2004, he obtained the German medical board certification in internal medicine.
In 2007, Prof. Markus Gerhard together with Christoph Mempel and Christian Wallasch won the Munich Business Plan Competition. In 2014, he co-founded the ImevaX GmbH, served as CSO until 2016 and subsequently returned full time to the TUM as a Professor. His extensive national and international network of eminent scientists is invaluable for ImevaX.
Prof Dr. med. M. Vieth
Prof Dr. Med. M. Vieth is the director and chief physician of the Institute of Pathology in Bayreuth since 2007. He has a special interest in the gastrointestinal tract, with focus of inflammatory and neoplastic patterns and pathways. He coauthored more than 450 articles.
Prof. Steven Moss, MD
Steven Moss is a Professor of Medicine in the Division of Gastroenterology at Brown University, USA as well as a clinical gastroenterologist working at Rhode Island Hospital and the Providence VA Medical Center. He also directs the Brown Gastroenterology Fellowship Training Program. Dr. Moss has longstanding clinical and research interests in the pathogenesis of H. pylori and its associated diseases, particularly in relation to gastric cancer.